Eli Ipp

7.0k total citations
84 papers, 2.8k citations indexed

About

Eli Ipp is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Eli Ipp has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Surgery and 21 papers in Molecular Biology. Recurrent topics in Eli Ipp's work include Pancreatic function and diabetes (33 papers), Diabetes Management and Research (25 papers) and Retinal Diseases and Treatments (14 papers). Eli Ipp is often cited by papers focused on Pancreatic function and diabetes (33 papers), Diabetes Management and Research (25 papers) and Retinal Diseases and Treatments (14 papers). Eli Ipp collaborates with scholars based in United States, Taiwan and Switzerland. Eli Ipp's co-authors include Roger H. Unger, Richard Dobbs, Hsu-Fang Chou, V. Harris, Pauline Genter, Lelio Orci, Nancy Berman, Wylie Vale, V. Schusdziarra and Sharon G. Adler and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Eli Ipp

83 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Ipp United States 30 1.0k 1.0k 975 436 430 84 2.8k
San‐e Ishikawa Japan 32 558 0.5× 731 0.7× 1.3k 1.4× 136 0.3× 382 0.9× 177 3.3k
Andreas Andersen Denmark 28 564 0.5× 1.7k 1.7× 625 0.6× 285 0.7× 302 0.7× 71 4.3k
Frédéric Preitner Switzerland 24 731 0.7× 651 0.6× 1.9k 2.0× 193 0.4× 1.1k 2.6× 33 4.0k
Julie A. Lovshin Canada 25 790 0.8× 1.7k 1.7× 672 0.7× 265 0.6× 126 0.3× 58 2.5k
Leen M. ‘t Hart Netherlands 30 818 0.8× 775 0.8× 1.5k 1.5× 201 0.5× 279 0.6× 98 3.0k
Toshihiko Inukai Japan 27 428 0.4× 816 0.8× 683 0.7× 108 0.2× 918 2.1× 128 2.8k
Renming Hu China 33 413 0.4× 930 0.9× 855 0.9× 94 0.2× 532 1.2× 105 3.1k
Lillian Recant United States 29 1.1k 1.0× 1000 1.0× 897 0.9× 368 0.8× 644 1.5× 124 2.9k
Stanley C. Rall United States 18 1.1k 1.0× 914 0.9× 994 1.0× 189 0.4× 252 0.6× 21 2.9k
K. Bridget Brosnihan United States 35 502 0.5× 2.0k 2.0× 1.5k 1.5× 549 1.3× 123 0.3× 80 5.1k

Countries citing papers authored by Eli Ipp

Since Specialization
Citations

This map shows the geographic impact of Eli Ipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Ipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Ipp more than expected).

Fields of papers citing papers by Eli Ipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Ipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Ipp. The network helps show where Eli Ipp may publish in the future.

Co-authorship network of co-authors of Eli Ipp

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Ipp. A scholar is included among the top collaborators of Eli Ipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Ipp. Eli Ipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virgilio, Christian de, et al.. (2023). Multidisciplinary Limb Salvage Service Reduces Major Amputations in Diabetic Foot Infections. Journal of the American Podiatric Medical Association. 113(2). 1 indexed citations
2.
McKean‐Cowdin, Roberta, Rohit Varma, Darryl Nousome, et al.. (2020). Genetic Susceptibility to Diabetic Retinopathy Using a Genetic Risk Score in Multiethnic Cohorts. Investigative Ophthalmology & Visual Science. 61(7). 3849–3849.
3.
Adams, Elizabeth, Pauline Genter, Kevin Sandow, et al.. (2017). The GLP-1 response to glucose does not mediate beta and alpha cell dysfunction in Hispanics with abnormal glucose metabolism. Diabetes Research and Clinical Practice. 135. 185–191. 1 indexed citations
4.
Kuo, Jane Z., Xiaoyi Gao, Xiuqing Guo, et al.. (2014). A Candidate-Wide Association Study of Diabetic Retinopathy in Latinos Implicates TNF Receptor Pathophysiology: Genetics of Latino Diabetic Retinopathy (GOLDR) and Los Angeles Latino Eye (LALES) studies. Investigative Ophthalmology & Visual Science. 55(13). 4509–4509. 1 indexed citations
5.
Sheu, Wayne Huey‐Herng, Jane Z. Kuo, I‐Te Lee, et al.. (2013). Genome-wide association study in a Chinese population with diabetic retinopathy. Human Molecular Genetics. 22(15). 3165–3173. 69 indexed citations
6.
Ipp, Eli, et al.. (2009). Detection of Undiagnosed Diabetes and Prediabetic States in High‐risk Emergency Department Patients. Academic Emergency Medicine. 16(5). 394–402. 47 indexed citations
7.
Mehrotra, Rajnish, Matthew J. Budoff, John E. Hokanson, et al.. (2005). Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney International. 68(3). 1258–1266. 65 indexed citations
8.
Pettitt, David J., et al.. (2005). Decreasing the Risk of Diabetic Retinopathy in a Study of Case Management. Diabetes Care. 28(12). 2819–2822. 25 indexed citations
9.
Genter, Pauline, Nancy Berman, M. Jacob, & Eli Ipp. (1998). Counterregulatory hormones oscillate during steady-state hypoglycemia. American Journal of Physiology-Endocrinology and Metabolism. 275(5). E821–E829. 12 indexed citations
10.
Mao, Catherine S., et al.. (1997). An Overnight Insulin Infusion Algorithm Provides Morning Normoglycemia and Can Be Used to Predict Insulin Requirements in Noninsulin-Dependent Diabetes Mellitus1. The Journal of Clinical Endocrinology & Metabolism. 82(8). 2466–2470. 12 indexed citations
11.
Genter, Pauline & Eli Ipp. (1994). Accuracy of Plasma Glucose Measurements in the Hypoglycemic Range. Diabetes Care. 17(6). 595–598. 29 indexed citations
12.
Chou, Hsu-Fang, Robert F. McGivern, Nancy Berman, & Eli Ipp. (1991). Oscillations of circulating plasma insulin concentrations in the rat. Life Sciences. 48(15). 1463–1469. 20 indexed citations
13.
Ipp, Eli, et al.. (1990). A Glucose Reduction Challenge in the Differential Diagnosis of Fasting Hypoglycemia: A Two-Center Study*. The Journal of Clinical Endocrinology & Metabolism. 70(3). 711–717. 14 indexed citations
14.
Ipp, Eli, et al.. (1989). Pentamidine–Induced Beta Cell Toxicity Is Not Preventable by High Glucose. The American Journal of the Medical Sciences. 298(2). 89–92. 8 indexed citations
15.
Ipp, Eli, et al.. (1987). Somatostatin Impairs Clearance of Exogenous Insulin in Humans. Diabetes. 36(5). 673–677. 24 indexed citations
16.
Ipp, Eli, Richard Dobbs, Roger Guillemin, & Roger H. Unger. (1978). Responses of the endocrine pancreas to morphine and β-endorphin. Clinical research. 26(3). 3 indexed citations
17.
Inbar, Michael, Ralph F. Goldman, Isia Bursuker, et al.. (1977). Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3037–41. 46 indexed citations
18.
Schusdziarra, V., Eli Ipp, & Roger H. Unger. (1977). Somatostatin, a physiologic regulator of nutrient influx. Diabetes. 26. 5 indexed citations
19.
Ipp, Eli, et al.. (1977). Hypothesis: Physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus. Life Sciences. 20(12). 2081–2086. 45 indexed citations
20.
Patton, G., et al.. (1976). Response of pancreatic immunoreactive somatostatin to arginine. Life Sciences. 19(12). 1957–1960. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026